Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes
Open Access
- 1 March 2007
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 292 (3), E829-E835
- https://doi.org/10.1152/ajpendo.00133.2006
Abstract
We determined whether insulin therapy changes liver fat content (LFAT) or hepatic insulin sensitivity in type 2 diabetes. Fourteen patients with type 2 diabetes (age 51 ± 2 yr, body mass index 33.1 ± 1.4 kg/m2) treated with metformin alone received additional basal insulin for 7 mo. Liver fat (proton magnetic resonance spectroscopy), fat distribution (MRI), fat-free and fat mass, and whole body and hepatic insulin sensitivity (6-h euglycemic hyperinsulinemic clamp combined with infusion of [3-3H]glucose) were measured. The insulin dose averaged 75 ± 10 IU/day (0.69 ± 0.08 IU/kg, range 24–132 IU/day). Glycosylated hemoglobin A1c(Hb A1c) decreased from 8.9 ± 0.3 to 7.4 ± 0.2% ( P < 0.001). Whole body insulin sensitivity increased from 2.21 ± 0.38 to 3.08 ± 0.40 mg/kg fat-free mass (FFM)·min ( P < 0.05). This improvement could be attributed to enhanced suppression of hepatic glucose production (HGP) by insulin (HGP 1.04 ± 0.28 vs. 0.21 ± 0.19 mg/kg FFM·min, P < 0.01). The percent suppression of HGP by insulin increased from 72 ± 8 to 105 ± 11% ( P < 0.01). LFAT decreased from 17 ± 3 to 14 ± 3% ( P < 0.05). The change in LFAT was significantly correlated with that in hepatic insulin sensitivity ( r = 0.56, P < 0.05). Body weight increased by 3.0 ± 1.1 kg ( P < 0.05). Of this, 83% was due to an increase in fat-free mass ( P < 0.01). Fat distribution and serum adiponectin concentrations remained unchanged while serum free fatty acids decreased significantly. Conclusions: insulin therapy improves hepatic insulin sensitivity and slightly but significantly reduces liver fat content, independent of serum adiponectin.Keywords
This publication has 53 references indexed in Scilit:
- Insulin therapy improves insulin actions on glucose metabolism and aortic wave reflection in type 2 diabetic patientsEuropean Journal of Clinical Investigation, 2003
- Insulin Decreases Human Adiponectin Plasma LevelsHormone and Metabolic Research, 2002
- Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 DiabetesEndocrine Reviews, 2002
- Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDMDiabetes Care, 1995
- Fatty Infiltration of the LiverInvestigative Radiology, 1993
- Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.JCI Insight, 1991
- Insulin Supplement in Type 2 Diabetic Patients with Secondary Failure to Oral Agents Ameliorates Hepatic and Peripheral Insulin Sensitivity but not Insulin SecretionDiabetic Medicine, 1990
- Kinetics of glucose disposal in whole body and across the forearm in man.JCI Insight, 1987
- Effects of Tolazamide and Exogenous Insulin on Insulin Action in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1986
- Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.JCI Insight, 1984